ArticleBMC oral health2025
Silymarin-functionalized nanohydroxyapatite-chitosan nanocomposite: a promising biomaterial for oral health applications.
Article in BMC oral health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNanohydroxyapatite (nHAP) is widely recognized for its potential biomedical applications, particularly in bone regeneration and periodontal therapy. Green synthesis methods, which are eco-friendly and non-toxic, have gained attention for the production of nanocomposites. Silymarin, a bioactive compound, can serve as both a reducing and stabilizing agent in such synthetic processes. In this study, we aimed to develop a nanohydroxyapatite nanocomposite using silymarin (SL) and chitosan (CH) and evaluate its antioxidant, antibacterial, and anti-inflammatory properties for oral health applications.
methodsNanohydroxyapatite nanocomposites were synthesized using a green synthesis technique, with silymarin acting as both reducing and stabilizing agent. Chitosan was incorporated to form the polymer-based nanocomposites. The synthesized materials (silymarin-chitosan, silymarin-nHAP, and nanocomposite) were characterized by Transmission Electron Microscopy (TEM), Scanning Electron Microscopy (SEM), and Fourier Transform Infrared Spectroscopy (FTIR) to assess their morphology and functional groups. Antioxidant activity was evaluated using the DPPH assay, and the antibacterial activity was tested against common oral pathogens. Biocompatibility was assessed using human gingival fibroblast (HGF) cells and cell viability was measured via live/dead cell assays using fluorescence imaging and in vitro migration assays. Wettability analysis was performed using a contact angle measurement technique to evaluate the surface hydrophilicity of the nanocomposite, a crucial factor for biointegration and tissue adhesion. Additionally, the anti-inflammatory potential was examined using the human red blood cell (HRBC) membrane stabilization assay, where the nanocomposite was evaluated for its ability to inhibit heat-induced hemolysis.
resultsThe characterization revealed the successful formation of nanoHA nanocomposites with distinct morphological features. Antioxidant assays indicated significant free radical scavenging activity, whereas antibacterial testing demonstrated effective inhibition of oral pathogens, including Streptococcus mutans and Porphyromonas gingivalis. Wettability analysis revealed a favorable contact angle, indicating enhanced surface hydrophilicity, which is beneficial for cell attachment and biointegration. Biocompatibility studies revealed that the nanocomposites exhibited minimal cytotoxicity and enhanced cell viability. Migration assays revealed favorable activity in promoting fibroblast migration, suggesting its potential for tissue regeneration. Furthermore, the HRBC membrane stabilization assay confirmed the anti-inflammatory potential of the nanocomposite, indicating its ability to protect erythrocytes against heat-induced hemolysis.
conclusionThe silymarin-chitosan-nanohydroxyapatite nanocomposite synthesized using green methods demonstrated high crystallinity, improved wettability, excellent biocompatibility, and multifunctional bioactivity, including antioxidant, antibacterial, and anti-inflammatory effects. The ability of the nanocomposite to support cell migration, inhibit oral pathogens, enhance surface hydrophilicity, and stabilize cell membranes suggests its potential application in oral health, particularly in bone regeneration, periodontal therapy, and inflammation management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.